Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard J. Sylvester*, Maurizio A. Brausi, Wim J. Kirkels, Wolfgang Hoeltl, Fernando Calais Da Silva, Philip H. Powell, Stephen Prescott, Ziya Kirkali, Cees van de Beek, Thierry Gorlia, Theo M. de Reijke

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

231 Citations (Web of Science)
Original languageEnglish
Pages (from-to)766-773
JournalEuropean Urology
Volume57
Issue number5
DOIs
Publication statusPublished - May 2010

Keywords

  • Bacillus Calmette-Guerin
  • Epirubicin
  • Instillation therapy
  • Isoniazid
  • Non-muscle-invasive bladder cancer
  • Randomized clinical trial
  • Urothelial carcinoma of the bladder

Cite this